The Cooper Companies, Inc. (NASDAQ:COO) Shares Bought by Versant Capital Management Inc

Versant Capital Management Inc grew its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 306.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 988 shares of the medical device company’s stock after purchasing an additional 745 shares during the period. Versant Capital Management Inc’s holdings in Cooper Companies were worth $91,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Ashton Thomas Securities LLC purchased a new position in shares of Cooper Companies during the 3rd quarter worth approximately $25,000. Covestor Ltd grew its holdings in Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after acquiring an additional 200 shares during the period. Brown Brothers Harriman & Co. raised its position in Cooper Companies by 191.0% in the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after acquiring an additional 275 shares in the last quarter. Friedenthal Financial acquired a new stake in Cooper Companies in the third quarter valued at $50,000. Finally, Cromwell Holdings LLC purchased a new stake in shares of Cooper Companies during the 3rd quarter worth $52,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ:COO opened at $91.79 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $18.32 billion, a PE ratio of 47.07, a P/E/G ratio of 2.52 and a beta of 0.97. The firm has a 50 day simple moving average of $99.16 and a 200-day simple moving average of $98.80. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The company had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The business’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.87 EPS. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the stock. Citigroup cut their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a report on Wednesday, December 11th. Wells Fargo & Company boosted their target price on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Finally, Morgan Stanley dropped their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $117.00.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.